Features

The Basel-based biotechnology company Therachon has raised an additional USD 5 million in its latest financing round. It also appointed Luca Santarelli as its new…

The US investment firm Versant Ventures has launched a new fund worth USD 400 million with the aim of investing in 20 to 25 biotechnology…

The Basel-based pharmaceutical company PIQUR Therapeutics is entering into a partnership with the French pharmaceutical group Pierre Fabre to collaborate in the field of dermato-oncology.